322 related articles for article (PubMed ID: 33776436)
1. A Triptolide Loaded HER2-Targeted Nano-Drug Delivery System Significantly Suppressed the Proliferation of HER2-Positive and BRAF Mutant Colon Cancer.
Yalikong A; Li XQ; Zhou PH; Qi ZP; Li B; Cai SL; Zhong YS
Int J Nanomedicine; 2021; 16():2323-2335. PubMed ID: 33776436
[TBL] [Abstract][Full Text] [Related]
2. Membrane protein-chimeric liposome-mediated delivery of triptolide for targeted hepatocellular carcinoma therapy.
Zheng Y; Kong F; Liu S; Liu X; Pei D; Miao X
Drug Deliv; 2021 Dec; 28(1):2033-2043. PubMed ID: 34569906
[TBL] [Abstract][Full Text] [Related]
3. Triptolide synergistically enhances antitumor activity of oxaliplatin in colon carcinoma in vitro and in vivo.
Liu Y; Xiao E; Yuan L; Li G
DNA Cell Biol; 2014 Jul; 33(7):418-25. PubMed ID: 24720675
[TBL] [Abstract][Full Text] [Related]
4. Triptolide abrogates growth of colon cancer and induces cell cycle arrest by inhibiting transcriptional activation of E2F.
Oliveira A; Beyer G; Chugh R; Skube SJ; Majumder K; Banerjee S; Sangwan V; Li L; Dawra R; Subramanian S; Saluja A; Dudeja V
Lab Invest; 2015 Jun; 95(6):648-659. PubMed ID: 25893635
[TBL] [Abstract][Full Text] [Related]
5. Triptolide Inhibits Invasion and Tumorigenesis of Hepatocellular Carcinoma MHCC-97H Cells Through NF-κB Signaling.
Wang H; Ma D; Wang C; Zhao S; Liu C
Med Sci Monit; 2016 May; 22():1827-36. PubMed ID: 27239780
[TBL] [Abstract][Full Text] [Related]
6. Triptolide inhibits CD133
Acikgoz E; Tatar C; Oktem G
J Cell Biochem; 2020 Jun; 121(5-6):3313-3324. PubMed ID: 31904143
[TBL] [Abstract][Full Text] [Related]
7. Herbal compound triptolide synergistically enhanced antitumor activity of amino-terminal fragment of urokinase.
Lin Y; Peng N; Li J; Zhuang H; Hua ZC
Mol Cancer; 2013 Jun; 12():54. PubMed ID: 23758884
[TBL] [Abstract][Full Text] [Related]
8. Targeting of super-enhancers and mutant BRAF can suppress growth of BRAF-mutant colon cancer cells via repression of MAPK signaling pathway.
Nakamura Y; Hattori N; Iida N; Yamashita S; Mori A; Kimura K; Yoshino T; Ushijima T
Cancer Lett; 2017 Aug; 402():100-109. PubMed ID: 28576751
[TBL] [Abstract][Full Text] [Related]
9. Synergistic antitumour effects of triptolide plus 10-hydroxycamptothecin onbladder cancer.
Wang T; Ding Y; Yang Y; Wang Z; Gao W; Li D; Wei J; Sun Y
Biomed Pharmacother; 2019 Jul; 115():108899. PubMed ID: 31063955
[TBL] [Abstract][Full Text] [Related]
10. Synergistic effect of triptolide combined with 5-fluorouracil on colon carcinoma.
Tang XY; Zhu YQ; Tao WH; Wei B; Lin XL
Postgrad Med J; 2007 May; 83(979):338-43. PubMed ID: 17488865
[TBL] [Abstract][Full Text] [Related]
11. Novel CD44-targeting and pH/redox-dual-stimuli-responsive core-shell nanoparticles loading triptolide combats breast cancer growth and lung metastasis.
Shi J; Ren Y; Ma J; Luo X; Li J; Wu Y; Gu H; Fu C; Cao Z; Zhang J
J Nanobiotechnology; 2021 Jun; 19(1):188. PubMed ID: 34162396
[TBL] [Abstract][Full Text] [Related]
12. Triptolide has anticancer and chemosensitization effects by down-regulating Akt activation through the MDM2/REST pathway in human breast cancer.
Xiong J; Su T; Qu Z; Yang Q; Wang Y; Li J; Zhou S
Oncotarget; 2016 Apr; 7(17):23933-46. PubMed ID: 27004407
[TBL] [Abstract][Full Text] [Related]
13. The Effect of Triptolide-Loaded Exosomes on the Proliferation and Apoptosis of Human Ovarian Cancer SKOV3 Cells.
Liu H; Shen M; Zhao D; Ru D; Duan Y; Ding C; Li H
Biomed Res Int; 2019; 2019():2595801. PubMed ID: 31240207
[TBL] [Abstract][Full Text] [Related]
14. Triptolide decreases tumor-associated macrophages infiltration and M2 polarization to remodel colon cancer immune microenvironment via inhibiting tumor-derived CXCL12.
Jiang X; Cao G; Gao G; Wang W; Zhao J; Gao C
J Cell Physiol; 2021 Jan; 236(1):193-204. PubMed ID: 32495392
[TBL] [Abstract][Full Text] [Related]
15. Synergistic antitumour effects of triptolide plus gemcitabine in bladder cancer.
Yang Y; Zhang LJ; Bai XG; Xu HJ; Jin ZL; Ding M
Biomed Pharmacother; 2018 Oct; 106():1307-1316. PubMed ID: 30119201
[TBL] [Abstract][Full Text] [Related]
16. Triptolide triggers the apoptosis of pancreatic cancer cells via the downregulation of Decoy receptor 3 expression.
Wang W; Li X; Sun W; Zhang L; Zhang M; Hong B; Lv G
J Cancer Res Clin Oncol; 2012 Sep; 138(9):1597-605. PubMed ID: 22581262
[TBL] [Abstract][Full Text] [Related]
17. Synergistic combination therapy of lung cancer using paclitaxel- and triptolide-coloaded lipid-polymer hybrid nanoparticles.
Liu J; Cheng H; Han L; Qiang Z; Zhang X; Gao W; Zhao K; Song Y
Drug Des Devel Ther; 2018; 12():3199-3209. PubMed ID: 30288024
[TBL] [Abstract][Full Text] [Related]
18. Prodrug polymeric micelles integrating cancer-associated fibroblasts deactivation and synergistic chemotherapy for gastric cancer.
Zheng S; Wang J; Ding N; Chen W; Chen H; Xue M; Chen F; Ni J; Wang Z; Lin Z; Jiang H; Liu X; Wang L
J Nanobiotechnology; 2021 Nov; 19(1):381. PubMed ID: 34802453
[TBL] [Abstract][Full Text] [Related]
19. The Inhibition Effect of Triptolide on Human Endometrial Carcinoma Cell Line HEC-1B: a in vitro and in vivo Studies.
Ni J; Wu Q; Sun ZH; Zhong J; Cai Y; Huang XE
Asian Pac J Cancer Prev; 2015; 16(11):4571-6. PubMed ID: 26107205
[TBL] [Abstract][Full Text] [Related]
20. Antitumor properties of triptolide: phenotype regulation of macrophage differentiation.
Li H; Li L; Mei H; Pan G; Wang X; Huang X; Wang T; Jiang Z; Zhang L; Sun L
Cancer Biol Ther; 2020; 21(2):178-188. PubMed ID: 31663424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
